✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Natco Pharma Ltd.

NATCOPHARM

Market Cap
₹19,772 Cr.
P/E
12.70

Natco Pharma Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
19,772 Cr
PE
PE
12.70
Prom Holding
Prom Holding
49.42 %
ROE (%)
ROE (%)
24.79
ROCE (%)
ROCE (%)
30.32
Div Yield (%)
Div Yield (%)
0.54
Sales
Sales
4,560 Cr
OPM (%)
OPM (%)
40.72 %
Debt to Equity
Debt to Equity
0.04
View more
Edit Ratio's

About

Natco Pharma Limited is a vertically integrated pharmaceutical company with a focus on researc… Read more
Low
775
52W Range
High
1135
  • Natco Pharma
  • Eris Lifesciences
  • Astrazeneca Pharma I
  • TJI Pharma

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New
Edit rows

Forensics

12 Yes

Positive for this company

2 Neutral

Neutral for this company

3 No

Negative for this company

0 No Data

Insufficient data to analyse

Market Share

0.07 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.74 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
16.71 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.11 %
(as of Nov 21)
Historic
Blood Related - Market Share
0.56 %
(as of Jul 22)
Historic
Cardiovascular - Market Share
30 %
(as of Mar 19)
Source/Historic
Copaxone - Market Share

Revenue mix

Product Wise Break-Up

Segment Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Formulation

Location Wise Break-Up

Therapeutic Area Break-Up - Formulation

Operating Profit Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • Number of ANDA's Approved By USFDA (.)
      Source
    • Domestic Sales Growth - YoY (%)
      Source
    • US DMF Filings (.)
      Source
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    Brands

    Afinitor
    Aubagio
    Imbruvica
    Kyprolis
    Nexavar
    Pomalyst
    Revlimid
    Sovaldi
    Tarceva
    Tykerb
    Zytiga

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    Suppliers

    • Laurus Labs Ltd.
    • Shaily Engineering Plastics Ltd.
    • Take Solutions Ltd.

    FAQs on Natco Pharma Ltd. Business

    Natco Pharma Limited is a vertically integrated pharmaceutical company that focuses on developing, manufacturing, and marketing pharmaceutical products, along with offering contract manufacturing services and crop health sciences division.

    Natco Pharma major competitors are Eris Lifesciences, Astrazeneca Pharma I, Wockhardt, Pfizer, Alembic Pharma, Jubilant Pharmova, Caplin Point Lab.
    Market Cap of Natco Pharma is ₹19,772 Crs.
    While the median market cap of its peers are ₹18,985 Crs.

    Natco Pharma seems to be financially stable compared to its competitors.
    The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

    View FAQ's On Shareprice

    Company Filing

    Discussions & Analysis

    Natco Pharma Ltd.
    A Deep Dive Into Natco Pharma - Numbers and Narratives
    Natco Pharma: Imminent Growth Cycle (?) - ValuePickr
    NatcoPharma - Complex generics focused manufacturer - Value Educator
    Business Analysis Of Natco Pharma - Value Educator
    Interview with Mr Rajeev Nannapaneni, Vice Chairman & CEO at Natco Pharma - Moneylife
    Natco Pharma: Chasing Optionalities - Ankush Agrawal
    Natco Pharma: Business Model Simplified - JST Investments
    Chasing Optionalities - SOIC
    View the discussion on ValuePickr
    Pharmaceuticals
    GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Nutraceuticals- Industry Overview - Value Educator
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Pharma Compliance In-Depth - Amit Rajan
    Deep Dive into Pharma Sector - Omkara Capital
    How The Pharma Industry Works - PPFAS
    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material